Form 8-K - Current report:
SEC Accession No. 0001144204-19-023918
Filing Date
2019-05-06
Accepted
2019-05-06 16:37:19
Documents
5
Period of Report
2019-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv520669_8k.htm 8-K 19795
2 EXHIBIT 99.1 tv520669_ex99-1.htm EX-99.1 360141
3 EXHIBIT 99.2 tv520669_ex99-2.htm EX-99.2 3193
4 GRAPHIC tv520669_ex99-1img01.jpg GRAPHIC 14046
5 GRAPHIC tv520669_ex99-2img01.jpg GRAPHIC 18665
  Complete submission text file 0001144204-19-023918.txt   429833
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 19799783
SIC: 2834 Pharmaceutical Preparations